After anti-PD1 treatment in NASH-related HCC mice, pre-existing HCC tissue showed no regression and there was an increase in CD8+/PD1+T cells in HCC tissue, suggesting that the activated immune cells may not play an immune surveillance role, but show the potential of tissue destruction (97). The gene discussed is CD8A; the disease is hepatocellular carcinoma.